Berger Amund Holte, Oftedal Bergithe Eikeland, Wolff Anette Susanne Bøe, Husebye Eystein Sverre, Knappskog Per Morten, Bratland Eirik, Johansson Stefan
Department of Clinical Science, University of Bergen, Bergen, Norway.
Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
Front Immunol. 2025 Apr 22;16:1572789. doi: 10.3389/fimmu.2025.1572789. eCollection 2025.
The Autoimmune Regulator, AIRE, acts as a transcriptional regulator in the thymus, facilitating ectopic expression of thousands of genes important for the process of negative T-cell selection and immunological tolerance to self. Pathogenic variants in the gene encoding AIRE are causing Autoimmune polyendocrine syndrome type 1 (APS-1), defined by multiorgan autoimmunity and chronic mucocutaneous candidiasis. More recently, Genome Wide Association Studies (GWAS) have also implicated AIRE in several common organ-specific autoimmune diseases including autoimmune primary adrenal insufficiency, type 1 diabetes and pernicious anemia.
We developed a highly sensitive cell-system approach based on HEK293FT cells transfected with AIRE that allowed us to characterise and functionally evaluate the transcriptional potential of genetic variants in the AIRE gene. By utilizing RNAseq with an average read depth of 100 million reads and 12 replicates per condition we have the statistical power and sensitivity to characterize the AIRE induced transcriptome in depth.
We confirm that our cell system recapitulates the expression of the vast majority of known AIRE induced genes including well-characterised tissue restricted antigens (TRAs). Our approach also increases the total number of identified AIRE induced genes by an order of magnitude compared to previously published strategies, including a comprehensive number of clinically relevant autoantigens.
Our cell-system approach differentiates between categories of AIRE variants on the transcriptional level, including the nonsense variant p.R257* (near complete loss of function), the p.C311Y variant associated with dominantly inherited APS-1 (severely impaired function), and the polygenic risk variant p.R471C (slightly increased function) linked to common organ-specific autoimmunity. The increased activity of p.R471C compared to wildtype indicates different molecular mechanisms for monogenic and polygenic AIRE related autoimmunity. We find that AIRE induced expression is characterised by a small absolute increase in expression levels of genes of both high and low tissue specificity.
自身免疫调节因子(AIRE)在胸腺中作为转录调节因子发挥作用,促进数千个对阴性T细胞选择和自身免疫耐受过程至关重要的基因的异位表达。编码AIRE的基因中的致病变异导致1型自身免疫性多内分泌腺综合征(APS-1),其特征为多器官自身免疫和慢性黏膜皮肤念珠菌病。最近,全基因组关联研究(GWAS)也表明AIRE与几种常见的器官特异性自身免疫性疾病有关,包括自身免疫性原发性肾上腺功能不全、1型糖尿病和恶性贫血。
我们基于用AIRE转染的HEK293FT细胞开发了一种高度敏感的细胞系统方法,使我们能够表征和功能评估AIRE基因中遗传变异的转录潜力。通过使用平均读取深度为1亿次读取且每种条件有12个重复样本的RNA测序,我们有统计能力和灵敏度来深入表征AIRE诱导的转录组。
我们证实我们的细胞系统概括了绝大多数已知的AIRE诱导基因(包括特征明确的组织限制性抗原(TRA))的表达。与先前发表的策略相比,我们的方法还将鉴定出的AIRE诱导基因总数增加了一个数量级,包括大量临床相关的自身抗原。
我们的细胞系统方法在转录水平上区分了AIRE变异的类别,包括无义变异p.R257*(功能几乎完全丧失)、与显性遗传的APS-1相关的p.C311Y变异(功能严重受损)以及与常见器官特异性自身免疫相关的多基因风险变异p.R471C(功能略有增加)。与野生型相比,p.R471C活性增加表明单基因和多基因AIRE相关自身免疫的分子机制不同。我们发现AIRE诱导的表达的特征是高组织特异性和低组织特异性基因的表达水平有小的绝对增加。